Astrazeneca Shs Sponsored American Deposit Receipt Repr 1 Sh $ 52.08
+0.81
| Last Trade: | 52.08 |
| Trade Time: | Sep 18 06:40 PM Eastern Daylight Time |
| Change: | 0.81 (1.58 %) |
| Prev Close: | 51.27 |
| Open: | 51.39 |
| Bid: | 52.08 |
| Ask: | 52.09 |
Quotes displayed are delayed by 15 minutes. Market data is provided by Xignite
ETF Alternatives
| Ticker | Name | Weight | % Change |
|---|---|---|---|
| DXPS | WisdomTree United Kingdom Hedged Equity | 4.86% | +0.30% |
| AXHE | iShares MSCI ACWI ex US Healthcare | 4.75% | +0.67% |
| IRY | SPDR S&P International HealthCare Sector | 4.61% | +1.16% |
| FDD | First Trust STOXX Euro Select Div Idx | 4.30% | +2.45% |
| PID | PowerShares Intl Dividend Achievers | 3.61% | +1.61% |
| EWU | iShares MSCI United Kingdom Index | 2.35% | +1.90% |
| FKU | First Trust United Kingdom AlphaDEX | 2.16% | +1.64% |
| IQDY | FlexShares International Qual Div Dyn | 1.92% | +2.46% |
| IQDF | FlexShares International Qual Div | 1.87% | +2.95% |
Competitors
| Ticker | Name | Volume | % Change |
|---|---|---|---|
| PFE | Pfizer Inc | 30.22M | +1.40% |
| MRK | Merck & Co Inc | 14.01M | +0.81% |
| BMY | Bristol Myers Squibb Co | 10.39M | +2.47% |
| JNJ | Johnson & Johnson | 10.09M | +0.95% |
| ELTP | Elite Pharmaceuticals Inc | 9.90M | +21.50% |
AZN Stock Analysis
-
Yet Another Failure Has Rigel Pharmaceuticals Almost Back To Square One
-
Does Amgen Deserve To Be Part Of The Biotech Bull Run?
-
Pharma & Biotech Stock Outlook - July/Aug 2013 - Industry Outlook
-
Pharma & Biotech Stock Outlook - July/Aug 2013 - Industry Outlook
-
Pipeline Setback for Roche - Analyst Blog
-
Omthera Seeks FDA Approval for Epanova - Analyst Blog
-
Free Managed Futures Book
Get the four benefits of managed futures as outlined in this booklet. -
View the Portfolios of the Worlds Top Investors, FREE!
Learn from Warren Buffett, George Soros and More! -
7 Proven Strategies for Market-Stomping Stocks
Discover Investing Strategies that will Benefit Every Investor Today!
Free Annual Reports